Orchestra BioMed Holdings Inc. (OBIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.33
• Market Cap: $245.62M
• EPS: $-1.80
• 52-Week High: $5.42
• 52-Week Low: $2.20

Market Sentiment

Orchestra BioMed Holdings Inc. currently has a Neutral sentiment score of 0.10.

About Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings, Inc. is a pioneering therapeutic device company based in New Hope, Pennsylvania, dedicated to advancing treatments for cardiovascular diseases through its innovative product line. Utilizing proprietary technologies, the company addresses crucial unmet clinical needs, significantly enhancing patient outcomes and therapeutic approaches in cardiology. With a strong commitment to improving healthcare access and quality, Orchestra BioMed positions itself as an emerging l...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Orchestra BioMed Holdings Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OBIO pay dividends?

Orchestra BioMed Holdings Inc. (OBIO) does not currently pay a regular dividend.

What is OBIO's market cap?

Orchestra BioMed Holdings Inc. (OBIO) has a market capitalization of $245.62M with a current stock price of $4.33.